- Home
- SAIC vs ACLX Comparison
SAIC vs ACLX Comparison
Compare SAIC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAIC
- ACLX
- Stock Information
- Founded
- SAIC 1969
- ACLX 2015
- Country
- SAIC United States
- ACLX United States
- Employees
- SAIC N/A
- ACLX N/A
- Industry
- SAIC EDP Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- SAIC Technology
- ACLX Health Care
- Exchange
- SAIC Nasdaq
- ACLX Nasdaq
- Market Cap
- SAIC 4.8B
- ACLX 4.4B
- IPO Year
- SAIC N/A
- ACLX 2022
- Fundamental
- Price
- SAIC $98.24
- ACLX $83.36
- Analyst Decision
- SAIC Hold
- ACLX Strong Buy
- Analyst Count
- SAIC 8
- ACLX 12
- Target Price
- SAIC $115.13
- ACLX $113.08
- AVG Volume (30 Days)
- SAIC 424.9K
- ACLX 551.2K
- Earning Date
- SAIC 12-04-2025
- ACLX 11-06-2025
- Dividend Yield
- SAIC 1.51%
- ACLX N/A
- EPS Growth
- SAIC 49.05
- ACLX N/A
- EPS
- SAIC 8.26
- ACLX N/A
- Revenue
- SAIC $7,460,000,000.00
- ACLX $56,979,000.00
- Revenue This Year
- SAIC $0.03
- ACLX N/A
- Revenue Next Year
- SAIC $1.36
- ACLX $210.73
- P/E Ratio
- SAIC $11.88
- ACLX N/A
- Revenue Growth
- SAIC 2.23
- ACLX N/A
- 52 Week Low
- SAIC $94.68
- ACLX $47.86
- 52 Week High
- SAIC $156.34
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- SAIC 42.67
- ACLX 50.14
- Support Level
- SAIC $95.71
- ACLX $84.60
- Resistance Level
- SAIC $100.95
- ACLX $94.07
- Average True Range (ATR)
- SAIC 2.51
- ACLX 3.96
- MACD
- SAIC 0.48
- ACLX -0.66
- Stochastic Oscillator
- SAIC 36.54
- ACLX 9.08
About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.